Delivery Order SPE2DB24D2106-SPE2DB25FAUSX

Award Date 3/6/25
Potential Completion Date 3/27/25
Potential Value $8.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is a $4,417.24 firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of 4567199030 - PROMACTA 12.5 MG TABLET UU 30S, a specialized pharmaceutical product, with a period of performance through February 28, 2025. DMS Pharmaceutical Group Inc. holds a significant $499,999,999 Indefinite Delivery...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $4,418.06, is for the delivery of PROMACTA 25 MG TABLET UU 30S, a pharmaceutical product, to support the medical supply needs of military healthcare facilities. The contract is not associated with any set-aside designation. DMS Pharmaceutical Group Inc....
This federal contract award, valued at $3,997.21, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract is a firm fixed-price delivery order with no set-aside designation, falling under the DLA's SPE2DB program, which is a $499,999,999 indefinite delivery contract that covers a wide range of pharmaceutical products to support the medical supply needs of Department of Defense (DoD) healthcare...
This is a delivery order award under contract SPE2DB24D2106 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $21,727.74 firm fixed-price contract is with the Defense Logistics Agency (DLA) for the delivery of pharmaceutical products, including PROMACTA 50 mg tablets. This award is not associated with any set-aside program. DMS Pharmaceutical Group holds an indefinite delivery contract, SPE2DB24FATWX, with DLA valued up to $4,999,999 through 2025...
This federal contract award, valued at $7,242.58, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PROMACTA 50 MG TABLET UU 30S, a pharmaceutical product. This contract award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,026.53 firm fixed-price delivery order is for the supply of PROMACTA 50 MG TABLET UU 30S, a pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award, valued at $7,106.11, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract is a delivery order for the supply of DOPTELET (30 TAB PK) 20 MG TAB UU 30S, a pharmaceutical product. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group Inc. under the DLA's SPE2DB program. This single-award IDC allows the DLA to issue...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $95,856.24 firm fixed-price delivery order is for the provision of a variety of pharmaceutical products and medical supplies to support the recurring medical needs of military healthcare facilities and veterans' medical centers. The award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,418.06, is for the supply of PROMACTA 25 MG TABLET to support military and federal healthcare programs. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,492.89 firm-fixed-price delivery order supports the DLA's procurement of PROMACTA 50 MG TABLET 30S, a pharmaceutical product. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for...
  • SPE2DB24D2106
    Indefinite Delivery Contract
  • SPE2DB24D2106-SPE2DB25FAUSX
    Delivery Order

This federal contract award is a delivery order valued at $8,835.30 issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract is for the provision of PROMACTA 25 MG TABLET, a specialized pharmaceutical product, to support the recurring medical supply needs of military healthcare facilities and veterans' medical centers.

The award is part of a larger Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group Inc. with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This IDC enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical supply requirements of the Department of Defense healthcare system. The contract does not have a set-aside designation, allowing DMS Pharmaceutical Group to leverage its woman-owned small business status to secure direct federal awards across multiple product categories and medical domains.

Generated 6/5/25, 10:23 AM